Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 1 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Illumina Inc | ILMN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 116.69 | 05:28:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 116.69 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 1 | - | 89.00 - 232.23 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:00:16 | 1 | $ 116.49 | USD |
Illumina (ILMN) Options Flow Summary
Illumina Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 18.54B | 158.90M | - | 4.5B | -1.16B | -7.31 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Illumina News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ILMN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 129.14 | 134.85 | 115.73 | 120.03 | 1,723,738 | -12.45 | -9.64% |
| 1 Month | 137.02 | 140.07 | 115.73 | 127.86 | 1,503,714 | -20.33 | -14.84% |
| 3 Months | 145.17 | 148.19 | 115.73 | 135.10 | 1,695,324 | -28.48 | -19.62% |
| 6 Months | 124.73 | 148.19 | 89.00 | 122.73 | 2,204,576 | -8.04 | -6.45% |
| 1 Year | 228.68 | 232.23 | 89.00 | 145.49 | 1,864,845 | -111.99 | -48.97% |
| 3 Years | 398.05 | 526.00 | 89.00 | 220.32 | 1,371,353 | -281.36 | -70.68% |
| 5 Years | 318.58 | 555.77 | 89.00 | 259.00 | 1,278,079 | -201.89 | -63.37% |
Illumina Description
| Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. |
